# Effect of SSRIs on Response to Psilocybin Therapy

> **NCT05594667** · PHASE2 · WITHDRAWN · sponsor: **Cybin Therapeutics Inc.**

## Conditions studied

- Depression
- Major Depressive Disorder
- Mild Depression
- Moderate Depression
- Depressive Disorder

## Interventions

- **DRUG:** Psilocybin

## Key facts

- **NCT ID:** NCT05594667
- **Lead sponsor:** Cybin Therapeutics Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2023-01-01
- **Primary completion:** 2023-03-14
- **Final completion:** 2023-03-14
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Funding
- **Last updated:** 2023-07-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05594667

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05594667, "Effect of SSRIs on Response to Psilocybin Therapy". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT05594667. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*